DLX5 and myeloid neoplasm: Although it is the first time to reveal DLX5 hypermethylation in myeloid neoplasms, previous study has also proved the phenomena of DLX5 methylation in breast cancer and neuroblastoma tumors by genome‐wide methylation analysis.16, 17